1.
Taçyıldız N, Tanyıldız HG, Ünal E, et al. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. Turk J Pediatr 2019; 61: 671-676. https://doi.org/10.24953/turkjped.2019.05.005